Detection of interleukins-6 and 8 in saliva as potential biomarkers of oral pre-malignant lesion and oral carcinoma: A breakthrough in salivary diagnostics in Pakistan

Pakistan Journal of Pharmaceutical Sciences

Volumn 30, Issue 3, 2017, Pages 817-823

  Khyani, Iqbal A Muhammad ^a   Qureshi, Masood A ^b   Mirza, Talat ^b   Farooq, M Umar ^a  

^a DOW UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

^b DOW UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

Author keywords

Biomarkers; Interleukins; Oral pre malignant lesions; Oral squamous cell carcinoma; Salivary diagnosis

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8; LEUKOTRIENE; TUMOR MARKER;

ADULT; ARTICLE; CANCER STAGING; CASE CONTROL STUDY; CONTROLLED STUDY; EARLY CANCER DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROPLASIA; FEMALE; HUMAN; LEUKOPLAKIA; LICHEN PLANUS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; ORAL SUBMUCOSAL FIBROSIS; PAKISTANI; QUANTITATIVE ANALYSIS; SALIVA ANALYSIS; AGED; CHEMISTRY; METABOLISM; MIDDLE AGED; MOUTH NEOPLASMS; PAKISTAN; SALIVA; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PAKISTAN; SALIVA; YOUNG ADULT;

EID: 85018937876     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Arellano-Garcia ME, Hu S, Wang J, Henson B, Zhou H and Chia D et al (2008). Multiplexed immunobeadbased assay for detection of oral cancer protein biomarkers in saliva. Oral Dis., 14(8): 705-12.
2. Bhurgri Y (2005). Cancer in the oral cavity-trends in Karachi South (1995-2002). Asian Pac. J. Cancer Prev., 6(1): 22-6.
3. Bhurgri Y, Rahim A, Bhutto K, Bhurgri A, Pinjani P and Usman A et al. (1998) Incidence of carcinoma of the oral cavity in Karachi Cancer Registry. J. Pak. Med. Assoc., 48(11): 321-5.
4. Brailo V, Boras VV, Lukac J, Lukenda DB, Alajbeg IZ and Milenovic A et al. (2012) Salivary and serum interleukin-1beta, interleukin-6 and tumour necrosis factor alpha in patients with leukoplakia and oral cancer. Med Oral Patol Oral Cir Bucal., 17(1): 10-5.
5. Brinkmann O, Kastratovic DA, Dimitri-jevic MV, Konstantinovic VS, Jelovac DB and Antic J et al (2011) Oral squamous cell carcinoma detection by salivary biomarkers in a Serbian population. Oral Oncol., 47: 51-5.
6. Culig Z. Interleukin-6 as a therapy target in oral squamous cell carcinoma. Expert Opin. Ther. Targets., 17(1): 53-9.
7. Duffy SA, Taylor JM, Terrell JE, Islam M, Li Y and Fowler KE et al. (2008). Interleukin-6 predicts recurrence and survival among head and neck cancer patients. Cancer, 113: 750-7.
8. Epstein JB, Zhang L and Rosin M (2002). Advances in the diagnosis of oral pre-malignant and malignant lesions. J. Can. Dent., 68: 617-21.
9. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM (2010). Estimates of world wide burden of cancer, 127: 2893-917.
10. Gan V and Wong D (2007). Oral fluid nanosensor test (OFNASET) with advanced electrochemical based molecular analysis platform. Ann. NY. Acad. Sci., 1098: 401-10.
11. Gillson ML and Shah KV (2001). Human papilloma virus associated head and neck squamous cell carcinoma, mounting evidence for an etiologic role of human papilloma virus in a subset of head and neck cancer. Curr. Opin. Oncol., 13: 183-8.
12. Greenberg BL, Glick M and Frantsve-Hawley J (2010). Dentist attitudes towards chairside screening for medical conditions. J. Am. Dent. Assoc., 141(1): 52-62.
13. Jamee MS, Eslami M, Moghadam FA and Sarafenjad AF (2008). Salivary concentration of TNF alpha, IL-6 and IL-8 in oral squanous cell carcinoma. Med Oral Pathol Cir Bucal., 13(5): 292-5.
14. Jemal A, Siegel R, Xu J and Ward E (2010). Cancer statistics 2010. CA Cancer J. Clin., 60: 277-300.
15. Jiang J, Park NJ, Hu S and Wong DT (2009). A universal pre analytic for concurrent stabilization of salivary protein RNA and DNA at ambient temperature. Arch Oral Biol., 54: 268-73.
16. Kao SY, Chu YW, Chen TW, Chang KW and Liu TY (2009). Detection and screening of oral cancer and precancer lesions. J. Chin. Med. Assoc., 75(5): 227-33.
17. Katakura A, Kamiyama I, Takano N, ShibaharaT, Muramatsu T and Ishihara K et al (2007). Comparision of salivary cytokines levels in oral cancer patients and healtly subjects. Bull Tokyo Dent coll., 48: 199-203.
18. Lee JM, Garon E and Wong DT (2009). Salivary Diagnostics. Orthod. Craniofac. Res., 12(3): 206-11.
19. Li Y, Zhou X, St John MA and Wong DT (2004). RNA profiling of cell free saliva using micro array technology. J. Dent. Res., 83: 199-203.
20. Mark J, Lie AK, Glattre E, Clark S, Hallmans G and Jellum E (2001). Human papilloma virus infection as risk factor for squamous cell carcinoma of the head and neck. N. Engl. J. Med., 344: 1125-31.
21. Mehrotra R, Gupta A, Singh M and Ibrahim R (2006). Application of cytology and molecular events in diagnosing pre-malignant or malignant oral lesion. Mol. Cancer, 5: 11-5.
22. Rhodus NL, Cheng R, Myers S, Miller L, Ho V and Ondrey F (2005). The feasibility of monitoring NFKappa B associated cytokines TNF-alpha, IL 1, alpha, IL 6 and IL8 in whole saliva for malignant transformation of oral lichen planus. Mol. Carcinog., 44(2): 77-82.
23. Rhodus NL, Ho V, Miller CS, Myers S, Ondrey F (2005). dependent cytokines level in saliva of patients with oral pre-neoplastic lesion and oral squamous cell carcinoma. Cancer Detect Prev., 29(1): 42-5.
24. Sato J, Goto J, Murata T, Kitamori S, Yamazaki Y and Satoh A et al. (2010). Changes in salivary interleukin-6 levels in patients with oral squamous cell carcinoma. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 110: 330-6.
25. Shah FD, Begum RN, Vajaria BN, Patel JB, Shukla SN and Patel PS (2011). A review on salivary genomics and proteomics biomarkers in oral cancer. Ind. J. Clin. Biochem., 26(4): 326-34.
26. Shrime MG, Gullane PJ, Dawson L, Kim J, Gilbert RW, Irish JC, Brown DH and Goldstein DP (2010). The impact of adjuvant radiotherapy on survival in T1-2 N1 squamous cell carcinoma of oral cavity. Arch Otolaryngol Head Neck Surg., 136: 225-8.
27. Silva P, Slevin NJ, Valentine H, Ryder D, Price P, West CML and Homer JJ (2010) Use of multiple biological markers in radiotherapy treated head and neck cancer. J. Laryngol. Otol., 124: 65-8.
28. St. John MA, Li Y, Zhou X, Denny P, Ho CM and Montemagno C (2004). Interleukin-6 and interleukin-8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg., 130: 929-35.
29. Subramanian S, Sankaranaryanan R, Bapat S, Somanathan T, Thomas G and Mathew B et al (2009) Cost-effectiveness of oral cancer screening; results from a clustered randomized controlled trial in India. Bull world Health organ., 87: 200-6.
30. Trivedi DJ, Trivedi CD, Hallikeri K and Udupa R (2012) Salivary Sialic acid as marker of oral cancer. Int. J. Int. Sci. Inn. Tech. Se.c B., 1(1): 48-50.
31. Vucicevic Boras V, Cikes N, Lukac J, Virag M and cekic-Arambasin A (2005). Salivary and serum interleukin-6 and basic fibroblast growth factor levels in patients with oral squamous cell carcinoma. Minerva stomatol., 54: 569-73.
32. Warnakulassuriya S (2009). Global epidemiology of oral and oropharyngeal cancer. Oral Oncol., 45: 309-316.
33. Zoiber BL, Mauk MG, Falla EM, Chen Z, Ziober AF and Bau HH (2008). Lab-on-A-chip for oral cancer screening and diagnosis. Head Neck., 30(1): 111-21.